Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662D F Hayes, H Yamauchi, G Broadwater, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patientsC L Shapiro, L Ayash, I J Webb, et al.British Journal of Cancer|December 3, 2009
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapyN L Henry, A Nguyen, F Azzouz, et al.European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.Clinical Pharmacology and Therapeutics|October 7, 2011
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and ageZ Desta, Y Kreutz, A T Nguyen, et al.The Pharmacogenomics Journal|August 24, 2016
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancerD L Hertz, K M Kidwell, N J Seewald, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)P Sharma, W E Barlow, A K Godwin, et al.The Pharmacogenomics Journal|May 8, 2009
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patientsJ M Rae, M J Sikora, N L Henry, et al.Nature Medicine|December 1, 1996
Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cellsC D Gimmi, B W Morrison, B A Mainprice, et al.Journal of the National Cancer Institute|October 16, 1996
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markersD F Hayes, R C Bast, C E Desch, et al.Pageof 13